Abstract
The complexity and fragmentation of the global medical device market is a significant barrier to international expansion by companies in this industry. The evolving marketing and regulatory requirements of both national and regional bodies necessitate constant monitoring of each market situation. This is especially true in emerging markets and outside the major European Union (EU) and US trade blocks. This paper, based on an extensive and ongoing study, summarises the key issues in a number of emerging markets around the world.
Get full access to this article
View all access options for this article.
